Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Related CRL
Valeant's Jublia Approved in the U.S. - Analyst Blog
Sanofi's Lemtrada Accepted for FDA Review - Analyst Blog

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A

 

Most Popular

Related Articles (CRL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters